Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam vs Carbamazepine Monotherapy in Newly Diagnosed Epilepsy
NCT00150735Phase 3Completed
- Sponsor
- UCB
- Start
- Jun 2002
- Primary completion
- Jul 2005
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of levetiracetam in epilepsy (2 arms), sponsored by UCB. Primary endpoint: Proportion of subjects with 6-month seizure freedom. Started Jun 2002; status: completed.
02
Drugs
levetiracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00150735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150735.